Otolaryngology Coding Alert

6 New J Codes Make Inhalation Coding Easier

Bonus: Don't let premix and compound solution requirements mix you up You now have greater flexibility in code selection when report inhalation solutions, thanks to HCPCS 2005 introducing six new J codes. Take Your Pick of New Nebulizer Med Codes This year you have two new codes for compounded inhalation solutions:

 J7616 - Albuterol, up to 5 mg and ipratropium bromide, up to 1 mg, compounded inhalation solution, administered through DME 
 J7617 - Levalbuterol, up to 2.5 mg and ipratropium bromide, up to 1 mg, compounded inhalation solution, administered through DME. HCPCS 2005 introduces J7616-J7617, along with J codes for albuterol:
 J7611 - Albuterol, inhalation solution, administered through DME, concentrated form, 1 mg 
 J7613 - Albuterol, inhalation solution, administered through DME, unit dose, 1 mg and levalbuterol:
 J7612 - Levalbuterol, inhalation solution, administered through DME, concentrated form, 0.5 mg
J7614 - Levalbuterol, inhalation solution, administered through DME, unit dose, 0.5 mg.

Old way: When a physician administered a nebulizer treatment containing a compounded inhalation solution of albuterol and levalbuterol, you should have assigned J7621 (Albuterol, all formulations, including separated isomers, up to 5 mg [albuterol] or 2.5 mg [levalbuterol], and ipratropium bromide, up to 1 mg, compounded inhalation solution, administered through DME). HCPCS 2005 deletes this J code.

New way: You should now specify whether the allergist uses a compounded inhalation solution of:
 albuterol and ipratropium bromide - J7616
 levalbuterol and ipratropium bromide - J7617. Bill Premixed Solution With Compounded Code Codes J7616 and J7617 may come in handy more than you think. Even if you premix albuterol/levalbuterol and ipratropium bromide, you should still use these new compounded inhalation solution J codes, says Kent J. Moore, manager of Health Care Financing and Delivery Systems for the American Academy of Family Physicians in Leawood, Kan.

Reason: "Medicare implies that premixed and compounded are synonymous," Moore says. In the 2005 fee schedule proposed rule (see page 61 of the document at www.cms.hhs.gov/providers/drugs/mpfs_05pr.pdf), CMS talks about suppliers furnishing albuterol and ipratropium bromide in "a premixed form (either commercially premixed or pharmacy-compounded)."

"So if a physician's office (like a pharmacy) mixes the two and administers them, they should use the compounded inhalation solution codes: J7616 or J7617," Moore says.

Example: "We mix levalbuterol and ipratropium bromide solutions ourselves," says Angela McDougal, CCS-P, coding analyst at Bend Memorial Clinic in Bend, Ore. The clinic orders premixed albuterol and ipratropium bromide.

The clinic should use the compounded codes for either solution (J7616-J7617) rather than the component codes, such as J7613 and J7644 (Ipratropium bromide, inhalation solution administered through DME, unit dose form, per mg) or J7614 and J7644.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Otolaryngology Coding Alert

View All